Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Health Group ( (HK:0673) ) just unveiled an update.
China Health Group Limited has undertaken an internal control review to enhance its compliance with the Hong Kong Stock Exchange’s listing rules. The company engaged PRO-WIS Risk Advisory Services Limited to conduct a thorough review of its internal control systems from April 2024 to March 2025. The review aimed to ensure effective compliance with the listing rules, including discussions with management and employees and identifying areas for improvement. The board considers the consultancy firm well-qualified for this task, given its extensive experience in internal controls and corporate governance across various sectors.
More about China Health Group
China Health Group Limited, operating in Hong Kong as CHG HS Limited, is incorporated in Bermuda and listed on the Hong Kong Stock Exchange. The company is involved in the healthcare industry and focuses on ensuring compliance with the listing regulations of the stock exchange.
Average Trading Volume: 1,313,088
Technical Sentiment Signal: Sell
Current Market Cap: HK$145M
Find detailed analytics on 0673 stock on TipRanks’ Stock Analysis page.